TOLANITY Trademark

Trademark Overview

On Thursday, January 16, 2020, a trademark application was filed for TOLANITY with the United States Patent and Trademark Office. The USPTO has given the TOLANITY trademark a serial number of 88761553. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2023. This trademark is owned by Pfizer Inc.. The TOLANITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
tolanity

General Information

Serial Number88761553
Word MarkTOLANITY
Filing DateThursday, January 16, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2022SOU EXTENSION 5 GRANTED
Thursday, December 1, 2022SOU EXTENSION 5 FILED
Monday, December 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 1, 2022TEAS EXTENSION RECEIVED
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2022SOU EXTENSION 4 GRANTED
Monday, May 2, 2022SOU EXTENSION 4 FILED
Monday, May 2, 2022TEAS EXTENSION RECEIVED
Thursday, December 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 30, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 30, 2021SOU EXTENSION 3 FILED
Tuesday, November 30, 2021TEAS EXTENSION RECEIVED
Thursday, May 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 4, 2021SOU EXTENSION 2 GRANTED
Tuesday, May 4, 2021SOU EXTENSION 2 FILED
Tuesday, May 4, 2021TEAS EXTENSION RECEIVED
Thursday, November 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 3, 2020SOU EXTENSION 1 GRANTED
Tuesday, November 3, 2020SOU EXTENSION 1 FILED
Tuesday, November 3, 2020TEAS EXTENSION RECEIVED
Tuesday, June 30, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 27, 2020ASSIGNED TO EXAMINER
Thursday, February 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 20, 2020NEW APPLICATION ENTERED

Related Keywords

tolanity preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological